Appili Therapeutics Inc. (TSX:APLI)
Canada
· Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Mar 9, 2026, 11:06 AM EST
Appili Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2017 |
| Net Income | -2.96 | -2.62 | -3.78 | -9.24 | -25.12 | -14.33 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0 | 0.02 | 0 | 0 | Upgrade
|
| Stock-Based Compensation | 0.05 | 0.12 | 0.19 | 0.88 | 2.04 | 1.17 | Upgrade
|
| Other Operating Activities | 1.29 | 3.59 | 0.45 | 1.47 | 1.5 | 0.04 | Upgrade
|
| Change in Accounts Receivable | 1.58 | -0.5 | -1.04 | 0.35 | 0.57 | -0.86 | Upgrade
|
| Change in Inventory | - | - | - | - | - | 0.04 | Upgrade
|
| Change in Accounts Payable | 0.04 | 0.19 | 1.38 | -4.16 | 1.92 | 3.21 | Upgrade
|
| Change in Other Net Operating Assets | -0.02 | 0.08 | 0.04 | -0.05 | 0.27 | -0.23 | Upgrade
|
| Operating Cash Flow | -0.01 | 0.87 | -2.46 | -10.1 | -19.08 | -11.45 | Upgrade
|
| Capital Expenditures | - | -0 | -0.03 | -0 | - | -0.01 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | 5.06 | -4.98 | Upgrade
|
| Investing Cash Flow | - | -0 | -0.03 | -0 | 5.06 | -4.99 | Upgrade
|
| Long-Term Debt Issued | - | 0.4 | 0.3 | 2.5 | 8 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.14 | -0.1 | -0.09 | -4.17 | -0.02 | Upgrade
|
| Net Debt Issued (Repaid) | -0.1 | 0.26 | 0.2 | 2.41 | 3.83 | -0.02 | Upgrade
|
| Issuance of Common Stock | 0.18 | - | - | 3.21 | 5.39 | 14.56 | Upgrade
|
| Other Financing Activities | -0.1 | -0.06 | -0.08 | 0.28 | 0.35 | 2.47 | Upgrade
|
| Financing Cash Flow | -0.03 | 0.19 | 0.12 | 5.91 | 9.56 | 17.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.07 | 0.07 | 0 | -0.01 | 0.06 | -0.02 | Upgrade
|
| Net Cash Flow | 0.03 | 1.13 | -2.37 | -4.2 | -4.4 | 0.55 | Upgrade
|
| Free Cash Flow | -0.01 | 0.87 | -2.49 | -10.1 | -19.08 | -11.46 | Upgrade
|
| Free Cash Flow Margin | -5.49% | 862.63% | -301.44% | -3022.65% | -1372.07% | - | Upgrade
|
| Free Cash Flow Per Share | - | 0.01 | -0.02 | -0.09 | -0.29 | -0.19 | Upgrade
|
| Cash Interest Paid | 0.09 | 0.06 | 0.07 | 0.48 | 0.09 | 0.02 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.01 | - | - | Upgrade
|
| Levered Free Cash Flow | -3.02 | -8.53 | -5.22 | -7.37 | -11.74 | -7.04 | Upgrade
|
| Unlevered Free Cash Flow | -2.2 | -6.69 | -4.2 | -6.77 | -10.77 | -6.97 | Upgrade
|
| Change in Working Capital | 1.6 | -0.23 | 0.66 | -3.24 | 2.49 | 1.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.